Deerfield Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500,000
Closed -$5.57M 164
2025
Q2
$5.57M Hold
500,000
0.1% 73
2025
Q1
$6.14M Buy
+500,000
New +$6.26M 0.12% 77

Other funds holding NPCE

Deerfield Management's NPCE Position: Q3 2025 in Review

Deerfield Management sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 500,000 shares — an estimated $5.57M sold.

Deerfield Management first reported a position in NPCE in Q1 2025 and held it in 2 quarters. The position peaked at $6.14M in Q1 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • Deerfield Management reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 500,000 Neuropace shares in Q3 2025, an estimated $5.57M.
  • Deerfield Management first reported a position in Neuropace in Q1 2025 and held it in 2 quarters.
  • Deerfield Management's Neuropace position peaked at $6.14M in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.